Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation. Tirofiban is a Platelet Aggregation Inhibitor. The physiologic effect of tirofiban is by means of Decreased Platelet Aggregation. It is grouped under the following drug class(es): Antiplatelets. Its therapeutic use is listed as hematologic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Agrastat and tirofibanum. Its PubChem CID is 60947.
Tirofiban
| CAS No | 144494-65-5 |
|---|---|
| Molecular Formula | C22H36N2O5S |
| Molecular Weight | 440.6 g/mol |
| Synonyms | (2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery.
The listed CAS number is 144494-65-5.
The listed molecular formula is C22H36N2O5S.
The listed molecular weight is 440.6 g/mol.
(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid.
The source lists Agrastat and tirofibanum.